Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Hokkaido University · The University of Tokyo · +22 more institutions
Abstract
In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is spreading rapidly around the world. Our phylogenetic analyses suggested that XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1 (a progeny of BA.2.75), during the summer of 2022. XBB.1 is the variant most profoundly resistant to BA.2/5 breakthrough infection sera to date and is more fusogenic than BA.2.75. The recombination breakpoint is located in the receptor-binding domain of spike, and each region of the recombinant spike confers immune evasion and increases fusogenicity. We further provide the structural basis for the interaction between XBB.1 spike and human ACE2. Finally, the…
Citation impact
- FWCI
- 66.11
- Percentile
- 100%
- References
- 93
Authors
85Topics & keywords
- Recombination
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Coronavirus disease 2019 (COVID-19)
- 2019-20 coronavirus outbreak
- Virology
- Sars virus
- Biology
- Betacoronavirus
Funding
- CGCRDF Global
- CFCanon Foundation in Europe
- NFNaito FoundationAwards: JP20ae0101047, 20H05773
- JAJapan Agency for Medical Research and DevelopmentAwards: JP22jk0210039, JP22fk0108617, CREST, JP22gm1810004, JP22wm0125008, JP223fa627009, JP21am0101093, JP22fk0410033, JP223fa627001, JP22fk0410055, JP22fk0410039, JP20ae0101047, JP21fk0108493, JP223fa627005, JP22wm0325009, JP21fk0108463, JP223fa727002, JP21gm1610005, 20H05773, JP21fk0108465, JP21fk0108494, JP22ama121037
- TBTokyo Biochemical Research Foundation
- ECEuropean CommissionAwards: LX22NPO5103, COVID-19
- DFDeutsche ForschungsgemeinschaftAward: SA 2676/3-1
- MOMinistry of Education, Culture, Sports, Science and TechnologyAwards: JP20ae0101047, 20H05773, 22K07103, CREST
- BFBundesministerium für Bildung und ForschungAward: 01KI20135
- UOUniversity of TokyoAward: COVID-19
- MMMochida Memorial Foundation for Medical and Pharmaceutical Research
- WFWaksman Foundation of Japan
- MRMedical Research CouncilAward: MC_PC_19026
- JSJapan Society for the Promotion of ScienceAwards: JP20H05873, 22K16375, 20K15767, 23K14526, 22K07103, JPJSCCA20190008, 20H05773, CREST, 21H02736
- IOInstitute of Medical Science, University of Tokyo
- CRCore Research for Evolutional Science and TechnologyAwards: JPMJCR20H8, JP223fa727002, JP223fa627001, JP21gm1610005, JPMJCR20H4, 20H05773
- PRPrecursory Research for Embryonic Science and Technology